Rebalix
Logo InvescoInvesco · sheet of 5 September 2026
ETF sheet · official issuer and register data

Invesco NASDAQ-100 Swap UCITS ETF Acc

EQQS · IE00BNRQM384 · class Acc · USD · domicile Ireland
Equity · United StatesSFDR art. 6
Index tracked: NASDAQ - 100 Notional NTR Index
TER
0.20%+ trans. 0.05%
Fund size
2.7 bn EUR
Tracking difference
+0.04%3-year avg
🇮🇹 tax rate
26.00%white list 0.00%
Replication
Synthetic (swap)
Income
Accumulating
Launch 22 Mar 2021 · costs from the KID as of 14 Aug 2026 · 242 securities held · 8 venues (ESMA register)

The fund’s objective — in the issuer’s words

From the Key Information Document (KID) · 2 Sept 2026
Investment objective: The investment objective of the Fund is to achieve the net total return performance of the NASDAQ-100 Index® (the "Index"), less fees, expenses and transaction costs. Dividend Policy: This Share Class does not pay you income, but instead reinvests it to grow your capital, in line with its stated objectives. Investment approach: The Fund is a passively managed ETF. To achieve the objective the Fund will use unfunded swaps ("Swaps"). These Swaps are an agreement between the Fund and an approved counterparty to exchange one stream of…

Performance since series start (in euro) — base 100

22 Mar 202113 Aug 2026 · dividends reinvested where declared by the issuer · converted at ECB rates
2022202320242025202624993245
High 249 (30 Jun 2026) · low 93 (5 Jan 2023) · last 245. Past performance is not indicative of future results.

Returns in euro

1 year+27.5%
3 years+94.0%
5 years+108.7%
10 yearsseries too young
Since series start+144.9%

Risk · 1 / 3 / 5 years

Volatility (ann.)19.64%20.53%23.22%
Max drawdown−11.95%−22.85%−35.14%
Sharpe1.191.030.59
Sortino1.741.510.84
Sharpe/Sortino: risk-free = ECB MRO avg; nominal volatility
Rebalix · EQQS · IE00BNRQM3841
RebalixEQQS · IE00BNRQM384 · sheet of 5 September 2026

Tracking difference — year by year

Fund minus index, complete calendar years · from issuer-declared series
YearFundIndexTD
2025+20.73%+20.77%−0.04%
2024+25.62%+25.58%+0.04%
2023+54.83%+54.70%+0.13%
2022−32.51%−32.56%+0.05%

Holdings

Synthetic replication: top positions of the substitute basket (swap collateral), not the fund’s exposure · 31 Aug 2026 · 242 securities · top-10 weight = 32.9%
Top holdingsWeight
AMAZON.COM INC6.5%
MICRON TECHNOLOGY INC5.3%
APPLE INC3.9%
NVIDIA CORP3.7%
CBRE GROUP INC - A2.4%
TESLA INC2.3%
UBS GROUP AG-REG2.3%
EXXONMOBIL HOLDINGS CORP2.2%
SNOWFLAKE INC2.2%
ZURICH INSURANCE GROUP AG2.2%

Listing venues

ESMA register (FIRDS) and official exchange lists
EQQX · Börse Düsseldorf, Börse Frankfurt, Börse Hamburg, Börse Hannover, Börse München / gettex, Börse Stuttgart, Tradegate Exchange, Xetra (Deutsche Börse)
+ 16 unmapped venues (MTF, RFQ, professional)

Official documents

Clickable links in the PDF
KID · www.invesco.com/content/dam/invesco/emea/en/product-documents/etf/shar
Factsheet · www.invesco.com/content/dam/invesco/emea/en/product-documents/etf/shar
Prospectus · www.invesco.com/content/dam/invesco/emea/en/product-documents/etf/umbr
The live sheet, always up to date
rebalix.com/en/etf/IE00BNRQM384
Series, distributions, holdings and documents refresh daily.
Sheet produced on 5 September 2026 · data as of the dates shown section by section. Sources: official issuer documents (KID, factsheet, NAV and total-return series, declared portfolio), ESMA register (FIRDS), European Central Bank (FX), Italian tax authority / issuer (white-list share). Public methodology: rebalix.com/en/methodology. “—” = not published by the source, never estimated.

Informational document generated by rebalix.com: facts only, no recommendations. Not investment advice or investment research under Directive 2014/65/EU (MiFID II), nor an offer or solicitation. Past performance is not indicative of, nor a guarantee of, future results; the value of an investment can go down as well as up. Before any decision read the issuer’s KID and Prospectus; tax treatment depends on individual circumstances. Trademarks and logos belong to their respective owners and only identify the instrument and its issuer: no affiliation, sponsorship or endorsement.

Rebalix · EQQS · IE00BNRQM3842